JEFFREY KREMPA: Open Payments
NPI 1619046968 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 83 payments from 11 companies in 2025. Trend: 2023 $1,679 · 2024 $1,618 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $303 |
| Lilly USA, LLC | 13 | $297 |
| Novo Nordisk Inc | 11 | $228 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Esperion Therapeutics, Inc. | 18 | $141 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| PFIZER INC. | 2 | $49 |
| ABBVIE INC. | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: JARDIANCE, OTEZLA, NEXLETOL, MOUNJARO, EVENITY, AIRSUPRA, LEQVIO, FARXIGA.
Industry payments across NY — which companies pay providers there.
